Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease

Atherosclerosis

Volumn 164, Issue 1, 2002, Pages 153-160

  Schumacher, A ^a   Seljeflot, I ^b   Lerkerod, A B ^a   Sommervoll, L ^a   Otterstad, J E ^a   Arnesen, H ^b  

^a Vestfold Central Hospital   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

C reactive protein; Chlamydia pneumoniae; Coronary heart disease; Fibrinogen; Helicobacter pylori; Interleukin 6; Tumor necrosis factor alpha

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 6; MARKER; TUMOR NECROSIS FACTOR; BACTERIUM ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROLOGY; STATISTICAL SIGNIFICANCE; BLOOD; CHLAMYDIASIS; CORONARY ARTERY DISEASE; HELICOBACTER INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY DISEASE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035996599     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00043-6     Document Type: Article

References (26)

1. Atherosclerosis - An inflammatory disease
2. Detection and localization of tumor necrosis factor in human atheroma
3. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis
4. Cytokine activation of vascular endothelium
5. Cytokines and endothelial cell biology
6. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Downregulation with essential fatty acids, ethanol and pentoxifylline
7. Chlamydia pneumoniae in atherosclerotic tissue
8. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response
9. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
10. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
11. Increased levels of soluble markers of endothelial dysfunction in patients with atherosclerotic heart disease
12. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
13. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
14. Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals
15. Chlamydia pneumoniae and atherosclerotic risk in populations: The role of seroepidemiology
16. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
17. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model
18. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
19. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae
20. Treatment of Chlamydia pneumoniae infection in adult asthma: A before-after trial
21. Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself
22. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide
23. Smoking is a potential confounder of the Chlamydia pneumoniae - Coronary artery disease association
24. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
25. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease
26. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction